Evidence map›Paper›PMID 34493898›Full record

ArticleJournal of family violence2022

Dabney P Evans, Casey D Xavier Hall, Raiza Wallace Guimarães da Rocha, Sandra Marques Prado, Marcos C Signorelli

Abstract read
In one paragraph

Article in Journal of family violence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dabney P EvansHubert Department of Global Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE, Atlanta, GA 30322 USA.ORCID 0000-0002-2201-5655
Casey D Xavier HallDepartment of Medical Social Sciences, Feinberg School of Medicine, Northwestern University Chicago, Chicago, IL USA.
Raiza Wallace Guimarães da RochaChamber of Public Health, Federal University of Paraná, Paraná, Brazil.
Sandra Marques PradoHouse of the Brazilian Woman of Curitiba, Curitiba, Brazil.
Marcos C SignorelliChamber of Public Health, Federal University of Paraná, Paraná, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this mixed-methods triangulation study was to assess the face validity and comprehension of a femicide risk assessment tool, the Danger Assessment-Brazil (DA-Brazil) among women seeking care in a one stop center for abused women in Curitiba, Brazil. Our secondary aim was to assess professionals' perceptions of feasibility for using the DA-Brazil in the same setting.

methodFifty-five women experiencing relationship violence completed the instrument and participated in cognitive interviews about their experience; professionals attending survivors were also interviewed.

resultsThe vast majority of women described the DA-Brazil instrument as being easy to comprehend (

conclusionThe overall face validity and comprehension of the DA-Brazil appears to be high. The majority of challenges were around the calendar activity. Professional perceptions of the DA-Brazil suggest a high degree of feasibility for its use in Brazilian healthcare settings. In order for the DA-Brazil to effectively be administered with facilitated support there is a need for training on the best use of the instrument. Accurate assessment of femicide risk is critical in a country like Brazil with high rates of femicide. The DA-Brazil provides a valid assessment of femicide risk and has the potential to trigger early intervention for those at risk. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10896-021-00313-1.

Indexed as

BrazilFemicideIPVRisk assessmentVAWViolence

Identifiers

PMID34493898
PMCPMC8414033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.